NCT03486652

Brief Summary

IBD-related arthropathy is one of a group of inflammatory arthritides considered as seronegative spondyloarthropathies, a group of disorders that also includes ankylosing spondylitis, psoriatic arthritis, reactive arthritis, and undifferentiated SpA. IBD-related SpA is mainly characterized by axial involvement but may also be associated with peripheral symptoms, such as synovitis, dactylitis, or enthesitis

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2018

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 23, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 3, 2018

Completed
28 days until next milestone

Study Start

First participant enrolled

May 1, 2018

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
Last Updated

April 3, 2018

Status Verified

April 1, 2018

Enrollment Period

8 months

First QC Date

January 23, 2018

Last Update Submit

April 1, 2018

Conditions

Inflammatory Bowel Diseases

Outcome Measures

Primary Outcomes (1)

  • the prevalence of rheumatological manifestations in cases of corhn's and ulcerative colitis

    evaluation of all cases for manifestations of rheumatological manifestations

    one year

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Any patient with inflammatory bowel diseases complaining of rheumatological manifestations clinical examination with espicial emphysis on the joints.

You may qualify if:

  • any patient with inflammatory bowel diseases complaining of rheumatological manifestations

You may not qualify if:

  • chronic hepatitis (c) patients
  • Rheumatoid factor positive patients
  • psoriatic patients.
  • systemic lupus.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Inflammatory Bowel Diseases

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

January 23, 2018

First Posted

April 3, 2018

Study Start

May 1, 2018

Primary Completion

January 1, 2019

Study Completion

April 1, 2019

Last Updated

April 3, 2018

Record last verified: 2018-04